Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Forde

Showing results (171-180 of 307) with videos related to

Pageof 31
Sort By:
Journal of the American Chemical Society|June 28, 2013
Partial oxidation of ethane to oxygenates using Fe- and Cu-containing ZSM-5Michael M Forde, Robert D Armstrong, Ceri Hammond, et al.
Nature Communications|February 14, 2024
Genomic epidemiology reveals geographical clustering of multidrug-resistant Escherichia coli ST131 associated with bacteraemia in WalesRhys T White, Matthew J Bull, Clare R Barker, et al.
JTO Clinical and Research Reports|July 8, 2024
First-line Osimertinib for Lung Cancer With Uncommon EGFR Exon 19 Mutations and EGFR Compound MutationsTia Cheunkarndee, Matthew Z Guo, Stefanie Houseknecht, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 13, 2014
Systemic therapy, clinical outcomes, and overall survival in locally advanced or metastatic pulmonary carcinoid: a brief reportPatrick M Forde, Craig M Hooker, Sosipatros A Boikos, et al.
BMC Genomics|June 26, 2021
MicroPIPE: validating an end-to-end workflow for high-quality complete bacterial genome constructionValentine Murigneux, Leah W Roberts, Brian M Forde, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 10, 2021
Mogamulizumab in Combination with Nivolumab in a Phase I/II Study of Patients with Locally Advanced or Metastatic Solid TumorsDavid S Hong, Olivier Rixe, Vi K Chiu, et al.
Lung Cancer (Amsterdam, Netherlands)|January 16, 2019
Real-world treatment patterns and survival of patients with BRAF V600-mutated metastatic non-small cell lung cancerLeora Horn, Joshua Bauml, Patrick M Forde, et al.
Journal of Bacteriology|February 10, 2026
NeuO-mediated O-acetylation of uropathogenic <i>Escherichia coli</i> K1 capsule enhances resistance to phage and neutrophil killingLachlan L Walker, Nguyen Thi Khanh Nhu, Zheng Jie Lian, et al.
Clinical Lung Cancer|March 24, 2020
Expanding Access to Lung Cancer Clinical Trials by Reducing the Use of Restrictive Exclusion Criteria: Perspectives of a Multistakeholder Working GroupPatrick M Forde, Phil Bonomi, Alice Shaw, et al.
Antimicrobial Agents and Chemotherapy|November 15, 2021
Plasmid-Mediated Ciprofloxacin Resistance Imparts a Selective Advantage on Escherichia coli ST131Minh-Duy Phan, Kate M Peters, Laura Alvarez Fraga, et al.
Pageof 31

Showing results (171-180 of 307) with videos related to

Sort By:
Pageof 31
Journal of the American Chemical Society|June 28, 2013
Partial oxidation of ethane to oxygenates using Fe- and Cu-containing ZSM-5Michael M Forde, Robert D Armstrong, Ceri Hammond, et al.
Nature Communications|February 14, 2024
Genomic epidemiology reveals geographical clustering of multidrug-resistant Escherichia coli ST131 associated with bacteraemia in WalesRhys T White, Matthew J Bull, Clare R Barker, et al.
JTO Clinical and Research Reports|July 8, 2024
First-line Osimertinib for Lung Cancer With Uncommon EGFR Exon 19 Mutations and EGFR Compound MutationsTia Cheunkarndee, Matthew Z Guo, Stefanie Houseknecht, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 13, 2014
Systemic therapy, clinical outcomes, and overall survival in locally advanced or metastatic pulmonary carcinoid: a brief reportPatrick M Forde, Craig M Hooker, Sosipatros A Boikos, et al.
BMC Genomics|June 26, 2021
MicroPIPE: validating an end-to-end workflow for high-quality complete bacterial genome constructionValentine Murigneux, Leah W Roberts, Brian M Forde, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 10, 2021
Mogamulizumab in Combination with Nivolumab in a Phase I/II Study of Patients with Locally Advanced or Metastatic Solid TumorsDavid S Hong, Olivier Rixe, Vi K Chiu, et al.
Lung Cancer (Amsterdam, Netherlands)|January 16, 2019
Real-world treatment patterns and survival of patients with BRAF V600-mutated metastatic non-small cell lung cancerLeora Horn, Joshua Bauml, Patrick M Forde, et al.
Journal of Bacteriology|February 10, 2026
NeuO-mediated O-acetylation of uropathogenic <i>Escherichia coli</i> K1 capsule enhances resistance to phage and neutrophil killingLachlan L Walker, Nguyen Thi Khanh Nhu, Zheng Jie Lian, et al.
Clinical Lung Cancer|March 24, 2020
Expanding Access to Lung Cancer Clinical Trials by Reducing the Use of Restrictive Exclusion Criteria: Perspectives of a Multistakeholder Working GroupPatrick M Forde, Phil Bonomi, Alice Shaw, et al.
Antimicrobial Agents and Chemotherapy|November 15, 2021
Plasmid-Mediated Ciprofloxacin Resistance Imparts a Selective Advantage on Escherichia coli ST131Minh-Duy Phan, Kate M Peters, Laura Alvarez Fraga, et al.
Pageof 31